In laboratory experiments, inhibiting Pin1 with already approved drugs made “cold” tumours responsive to immunotherapy.
Read MoreNovember 2, 2026


In laboratory experiments, inhibiting Pin1 with already approved drugs made “cold” tumours responsive to immunotherapy.
Read More